Related Experiment Videos
Time-dependent changes in rat brain cholinergic receptor expression after experimental brain injury
S Leigh Verbois1, Stephen W Scheff, James R Pauly
1Division of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky 40536-0082, USA.
Journal of Neurotrauma
|January 25, 2003
Summary
Traumatic brain injury (TBI) significantly reduces alpha7 nicotinic acetylcholine receptors (alpha7* nAChr) expression, with deficits appearing rapidly and persisting for weeks. These persistent changes in alpha7* nAChr may impair recovery after brain injury.
Area of Science:
- Neuroscience
- Neurobiology
- Neuropharmacology
Background:
- Neurotransmitter receptor alterations are implicated in the deficits following traumatic brain injury (TBI).
- Previous research identified widespread deficits in alpha7 nicotinic acetylcholine receptor (alpha7* nAChr) expression two days post-TBI.
Purpose of the Study:
- To investigate the temporal profile of alpha7* nAChr expression changes over a broader range of recovery intervals following TBI.
- To compare TBI-induced alterations in alpha7* nAChr with other neurotransmitter receptors.
Main Methods:
- Moderate cortical contusion brain injury was induced in animals.
- Quantitative autoradiography was employed to measure cholinergic and glutamate receptor subtype expression at various time points (1 hour to 21 days post-TBI).
- Kinetic analysis assessed receptor binding affinity changes.
Main Results:
- Alpha7* nAChr expression showed significant decreases as early as 1 hour post-TBI, with deficits persisting up to 21 days in some regions.
- Binding affinity of alpha7* nAChr was not significantly altered by TBI.
- Changes in other receptors (alpha3*/alpha4* nACh, muscarinic, NMDA) were less pronounced and more transient.
Conclusions:
- Alpha7* nAChr is highly sensitive to TBI-induced plasticity.
- Persistent deficits in alpha7* nAChr expression following TBI may contribute to impaired functional recovery.
- The findings highlight the critical role of alpha7* nAChr in TBI pathophysiology.